{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:04:46Z","timestamp":1792800286165,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Graduate Innovation Fund of Jilin University","award":["2022241"],"award-info":[{"award-number":["2022241"]}],"id":[{"id":"https:\/\/ror.org\/00js3aw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Graduate Innovation Fund of Jilin University","award":["2022241"],"award-info":[{"award-number":["2022241"]}],"id":[{"id":"https:\/\/ror.org\/00js3aw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Graduate Innovation Fund of Jilin University","award":["2022241"],"award-info":[{"award-number":["2022241"]}],"id":[{"id":"https:\/\/ror.org\/00js3aw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the General Program of National Natural Science Foundation of China","award":["82370934"],"award-info":[{"award-number":["82370934"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science and Technology Department of Jilin Province","award":["20220401102YY"],"award-info":[{"award-number":["20220401102YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-04792-8","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:14:43Z","timestamp":1724930083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The preventive effect of photocrosslinked Hep\/GelMA hydrogel loaded with PRF on MRONJ"],"prefix":"10.1186","volume":"24","author":[{"given":"Lu","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"3","key":"4792_CR1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1021\/acs.jmedchem.0c01292","volume":"64","author":"JS BARBOSA","year":"2021","unstructured":"Barbosa JS, Almeida Paz FA, Braga SS, Bisphosphonates. Old friends of bones and New trends in clinics [J]. J Med Chem. 2021;64(3):1260\u201382.","journal-title":"J Med Chem"},{"issue":"10329","key":"4792_CR2","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"REID I R","year":"2022","unstructured":"Reid IR. Billington EO. Drug therapy for osteoporosis in older adults [J]. Lancet (London England). 2022;399(10329):1080\u201392.","journal-title":"Lancet (London England)"},{"key":"4792_CR3","doi-asserted-by":"crossref","unstructured":"Kuznik A, Pazdzierniok-Holewa A, Jewula P et al. Bisphosphonates-much more than only drugs for bone diseases [J]. Eur J Pharmacol, 2020, 866.","DOI":"10.1016\/j.ejphar.2019.172773"},{"issue":"3","key":"4792_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1759720X13477714","volume":"5","author":"NB DIAB D L, WATTS","year":"2013","unstructured":"Diab DL, Watts NB. Bisphosphonate drug holiday: who, when and how long [J]. Therapeutic Adv Musculoskelet Disease. 2013;5(3):107\u201311.","journal-title":"Therapeutic Adv Musculoskelet Disease"},{"issue":"10","key":"4792_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMc062792","volume":"356","author":"PAPAPOULOS S E","year":"2007","unstructured":"Papapoulos SE, Cremers SCL, M. Prolonged bisphosphonate release after treatment in children [J]. N Engl J Med. 2007;356(10):1075\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"4792_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R BARON","year":"2011","unstructured":"Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: different mechanisms of action and effects [J]. Bone. 2011;48(4):677\u201392.","journal-title":"Bone"},{"issue":"10","key":"4792_CR7","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"J RUGGIERO S L, DODSON T B, FANTASIA","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the Jaw-2014 update [J]. J Oral Maxillofac Surg. 2014;72(10):1938\u201356.","journal-title":"J Oral Maxillofac Surg"},{"key":"4792_CR8","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, et al. American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update [J]. Journal of oral and maxillofacial surgery. official journal of the American Association of Oral and Maxillofacial Surgeons; 2022.","DOI":"10.1016\/j.joms.2022.02.008"},{"issue":"9","key":"4792_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"MARX R E","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic [J]. J Oral Maxillofac Surg. 2003;61(9):1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"key":"4792_CR10","doi-asserted-by":"crossref","unstructured":"Taysi AE, Cevher E, Sessevmez M et al. The efficacy of sustained-release chitosan microspheres containing recombinant human parathyroid hormone on MRONJ [J]. Brazilian Oral Res, 2019, 33.","DOI":"10.1590\/1807-3107bor-2019.vol33.0086"},{"key":"4792_CR11","doi-asserted-by":"crossref","unstructured":"Hadad H, Kawamata de Jesus L, Piquera Santos AF et al. Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw [J]. Sci Rep, 2022, 12(1).","DOI":"10.1038\/s41598-022-20128-4"},{"issue":"5","key":"4792_CR12","first-page":"332","volume":"35","author":"Y GONEN Z B, ASAN C","year":"2017","unstructured":"Gonen ZB, Asan CY. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin [J]. Cranio-the J Craniomandib Sleep Pract. 2017;35(5):332\u20136.","journal-title":"Cranio-the J Craniomandib Sleep Pract"},{"issue":"1","key":"4792_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.joms.2017.06.004","volume":"76","author":"G MALUF","year":"2018","unstructured":"Maluf G, Caldas RJ, Silva Santos PS. Use of leukocyte- and platelet-rich fibrin in the treatment of medication-related osteonecrosis of the Jaws [J]. J Oral Maxillofac Surg. 2018;76(1):88\u201396.","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"4792_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","volume":"78","author":"S SZENTPETERI","year":"2020","unstructured":"Szentpeteri S, Schmidt L, Restar L, et al. The effect of platelet-rich fibrin membrane in Surgical Therapy of Medication-related osteonecrosis of the Jaw [J]. J oral Maxillofacial Surgery: Official J Am Association Oral Maxillofacial Surg. 2020;78(5):738\u201348.","journal-title":"J oral Maxillofacial Surgery: Official J Am Association Oral Maxillofacial Surg"},{"issue":"3","key":"4792_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tripleo.2005.07.012","volume":"101","author":"J CHOUKROUN","year":"2006","unstructured":"Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 2006;101(3):299\u2013303.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology"},{"key":"4792_CR16","doi-asserted-by":"crossref","unstructured":"Jamalpour MR, Shahabi S, Baghestani M et al. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study [J]. BMC Oral Health, 2022, 22(1).","DOI":"10.1186\/s12903-022-02275-2"},{"issue":"4","key":"4792_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.actbio.2005.03.002","volume":"1","author":"BENOIT D S W","year":"2005","unstructured":"Benoit DSW, Anseth KS. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation [J]. Acta Biomater. 2005;1(4):461\u201370.","journal-title":"Acta Biomater"},{"issue":"1","key":"4792_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/bm990017d","volume":"1","author":"B VAN DEN BULCKE A I, BOGDANOV","year":"2000","unstructured":"van den Bulcke AI, Bogdanov B, de Rooze N, et al. Structural and rheological properties of methacrylamide modified gelatin hydrogels [J]. Biomacromolecules. 2000;1(1):31\u20138.","journal-title":"Biomacromolecules"},{"issue":"6","key":"4792_CR19","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.biomaterials.2009.10.040","volume":"31","author":"LIU","year":"2010","unstructured":"Liu, Y, Chan-Park MB. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture [J]. Biomaterials. 2010;31(6):1158\u201370.","journal-title":"Biomaterials"},{"issue":"3","key":"4792_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1039\/C9BM01446B","volume":"9","author":"J ZHANG","year":"2021","unstructured":"Zhang J, Liu X, Ma K, et al. Collagen\/heparin scaffold combined with vascular endothelial growth factor promotes the repair of neurological function in rats with traumatic brain injury [J]. Biomaterials Sci. 2021;9(3):745\u201364.","journal-title":"Biomaterials Sci"},{"issue":"6","key":"4792_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2165\/11585470-000000000-00000","volume":"71","author":"EM LEWIECKI","year":"2011","unstructured":"Lewiecki EM. Safety of long-term bisphosphonate therapy for the management of osteoporosis [J]. Drugs. 2011;71(6):791\u2013814.","journal-title":"Drugs"},{"issue":"2","key":"4792_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","volume":"57","author":"GREENEP WYSOWSKI D K","year":"2013","unstructured":"Wysowski DK Greenep. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012 [J]. Bone. 2013;57(2):423\u20138.","journal-title":"Bone"},{"key":"4792_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jdent.2016.06.005","volume":"52","author":"A ANWANDTER","year":"2016","unstructured":"Anwandter A, Bohmann S, Nally M, et al. Dimensional changes of the post extraction alveolar ridge, preserved with leukocyte- and platelet Rich Fibrin: a clinical pilot study [J]. J Dent. 2016;52:23\u20139.","journal-title":"J Dent"},{"issue":"3","key":"4792_CR24","first-page":"221","volume":"5","author":"JE SCOTT","year":"1965","unstructured":"Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions [J]. Histochemie Histochem Histochimie. 1965;5(3):221\u201333.","journal-title":"Histochemie Histochem Histochimie"},{"key":"4792_CR25","doi-asserted-by":"crossref","unstructured":"Yan R, Jiang R. Hu L, Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ) [J]. Int J Oral Sci, 2022, 14(1).","DOI":"10.1038\/s41368-022-00182-4"},{"key":"4792_CR26","doi-asserted-by":"crossref","unstructured":"Reid IR, Green JR, Lyles KW et al. Zoledronate [J] Bone, 2020, 137.","DOI":"10.1016\/j.bone.2020.115390"},{"key":"4792_CR27","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.2147\/IJN.S305361","volume":"16","author":"J HUANG","year":"2021","unstructured":"Huang J, Wang L. Small extracellular vesicles derived from adipose tissue prevent bisphosphonate-related osteonecrosis of the Jaw by promoting angiogenesis [J]. Int J Nanomed. 2021;16:3161\u201372.","journal-title":"Int J Nanomed"},{"key":"4792_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bone.2017.12.025","volume":"108","author":"JM MESSER J G, CALLE J L M, JIRON","year":"2018","unstructured":"Messer JG, Calle JLM, Jiron JM, et al. Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis [J]. Bone. 2018;108:79\u201388.","journal-title":"Bone"},{"issue":"3","key":"4792_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/odi.13275","volume":"26","author":"W YU","year":"2020","unstructured":"Yu W, Su J. The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice [J]. Oral Dis. 2020;26(3):609\u201320.","journal-title":"Oral Dis"},{"issue":"11","key":"4792_CR30","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","volume":"184","author":"C WILLIAMS D W, LEE","year":"2014","unstructured":"Williams DW, Lee C, Kim T, et al. Impaired bone resorption and woven bone formation are Associated with Development of Osteonecrosis of the Jaw-Like lesions by Bisphosphonate and Anti-receptor Activator of NF-kappa B ligand antibody in mice [J]. Am J Pathol. 2014;184(11):3084\u201393.","journal-title":"Am J Pathol"},{"key":"4792_CR31","doi-asserted-by":"crossref","unstructured":"Du W, Yang M, Kim T et al. Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice [J]. Int J Oral Sci, 2022, 14(1).","DOI":"10.1038\/s41368-022-00166-4"},{"issue":"10","key":"4792_CR32","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.ajpath.2018.06.019","volume":"188","author":"T KIM","year":"2018","unstructured":"Kim T, Kim S, Song M, et al. Removal of pre-existing Periodontal Inflammatory Condition before tooth extraction ameliorates medication-related osteonecrosis of the Jaw-Like Lesion in mice [J]. Am J Pathol. 2018;188(10):2318\u201327.","journal-title":"Am J Pathol"},{"issue":"3","key":"4792_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","volume":"77","author":"Y LIU","year":"1995","unstructured":"Liu Y, Cox SR, Morita T, et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5\u2019 enhancer [J]. Circul Res. 1995;77(3):638\u201343.","journal-title":"Circul Res"},{"key":"4792_CR34","doi-asserted-by":"crossref","unstructured":"Ozalp O, Yildirimyan N, Ozturk C et al. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin [J]. BMC Oral Health, 2021, 21(1).","DOI":"10.1186\/s12903-021-01965-7"},{"key":"4792_CR35","doi-asserted-by":"crossref","unstructured":"Tenore G, Zimbalatti A, Rocchetti F et al. Management of medication-related osteonecrosis of the Jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective study [J]. J Clin Med, 2020, 9(11).","DOI":"10.3390\/jcm9113505"},{"issue":"25","key":"4792_CR36","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N YAROM","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, et al. Medication-related osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline [J]. J Clin Oncol. 2019;37(25):2270\u2013.","journal-title":"J Clin Oncol"},{"key":"4792_CR37","doi-asserted-by":"crossref","unstructured":"Bennardo F, Gallelli L, Palleria C et al. Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures [J]. BMC Oral Health. 2023;23(1).","DOI":"10.1186\/s12903-023-02814-5"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04792-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:15:01Z","timestamp":1724930101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04792-8","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were done under the guidelines and regulations of ARRIVE guidelines. Carried out all animal-related experiments in the Laboratory Animal Center of Jilin University. Reviewed and approved all experiments by the Institutional Animal Care and Use Committee and complied with Jilin University\u2019s and the state\u2019s requirements for the ethical welfare of experimental animals (China, Protocol number: SYXK2023-0010). Controlled the breeding conditions in strict accordance with GB14925.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1010"}}